David Gao

David Gao has filed trades across 2 companies (mainly through SEC (Form 4)), most often in China Biologic Products, Inc. and Beijing Med Pharm Corp. In total, 25 filings cover trades dated from 22 May 2008 to 1 March 2017.

On the open market, the record shows 7 purchases worth €158k and 12 sales worth €35.3M. Taken together, the sales exceed the purchases by €35.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants. So far in 2017, the count stands at no purchases and 2 sales.

The median purchase comes to €20k.

The record was last updated on 2 March 2017 with an open-market sale (€6.0M) in China Biologic Products, Inc. The last insider purchase was made public on 17 September 2012, 5,149 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.